GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ME Therapeutics Holding Inc (XCNQ:METX) » Definitions » PB Ratio

ME Therapeutics Holding (XCNQ:METX) PB Ratio : 70.34 (As of Dec. 14, 2024)


View and export this data going back to 2023. Start your Free Trial

What is ME Therapeutics Holding PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-12-14), ME Therapeutics Holding's share price is C$4.15. ME Therapeutics Holding's Book Value per Share for the quarter that ended in Aug. 2024 was C$0.06. Hence, ME Therapeutics Holding's PB Ratio of today is 70.34.

The historical rank and industry rank for ME Therapeutics Holding's PB Ratio or its related term are showing as below:

XCNQ:METX' s PB Ratio Range Over the Past 10 Years
Min: 0   Med: 0   Max: 373.53
Current: 65.87

During the past 3 years, ME Therapeutics Holding's highest PB Ratio was 373.53. The lowest was 0.00. And the median was 0.00.

XCNQ:METX's PB Ratio is ranked worse than
98.91% of 1281 companies
in the Biotechnology industry
Industry Median: 2.48 vs XCNQ:METX: 65.87

During the past 12 months, ME Therapeutics Holding's average Book Value Per Share Growth Rate was 168.20% per year.

Back to Basics: PB Ratio


ME Therapeutics Holding PB Ratio Historical Data

The historical data trend for ME Therapeutics Holding's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ME Therapeutics Holding PB Ratio Chart

ME Therapeutics Holding Annual Data
Trend Aug22 Aug23 Aug24
PB Ratio
- - 46.61

ME Therapeutics Holding Quarterly Data
Aug22 Dec22 May23 Aug23 Nov23 Feb24 May24 Aug24
PB Ratio Get a 7-Day Free Trial - 29.41 75.86 77.34 46.61

Competitive Comparison of ME Therapeutics Holding's PB Ratio

For the Biotechnology subindustry, ME Therapeutics Holding's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ME Therapeutics Holding's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ME Therapeutics Holding's PB Ratio distribution charts can be found below:

* The bar in red indicates where ME Therapeutics Holding's PB Ratio falls into.



ME Therapeutics Holding PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

ME Therapeutics Holding's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Aug. 2024)
=4.15/0.059
=70.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


ME Therapeutics Holding  (XCNQ:METX) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


ME Therapeutics Holding PB Ratio Related Terms

Thank you for viewing the detailed overview of ME Therapeutics Holding's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


ME Therapeutics Holding Business Description

Comparable Companies
Traded in Other Exchanges
Address
177 Robson St., Vancouver, BC, CAN, V6B 0N3
ME Therapeutics Holding Inc operates its business through ME Therapeutics. It is a preclinical-stage biotechnology company working on novel cancer-fighting drugs in the field of Immuno-Oncology (IO). It is developing preclinical data for its myeloid-targeted candidate assets using validated cancer models.

ME Therapeutics Holding Headlines

No Headlines